Search
Filters
Clear All
  • 4

Phase

  • 1
  • 3
  • 4
  • 3

Found 4 Medulloblastoma trials

A listing of Medulloblastoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients

S
Sandeep Batra, MD
3-21 years
All genders
This phase II trial studies how well reduced doses of radiation therapy to the brain and spine (craniospinal) and chemotherapy work in treating patients with newly diagnosed type of brain tumor called WNT)/Wingless (WNT)-driven medulloblastoma.
Learn More

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

S
Sandeep Batra, MD
3-21 years
All genders
Phase 3
Interventional
This phase III trial tests two hypotheses in patients with low-risk and average-riskdulloblastoma. Medulloblastoma is a type of cancer that occurs in the back of the brain. The term, risk, refers to the chance of the cancer coming back after treatment. Subjects withw-risk medulloblastoma typically have a lower chance of …
Learn More

HeadStart4: Newly Diagnosed Children (

D
Daniel Runco, MD
All genders
This is a prospective randomized clinical trial, to determine whether dose-intensive tandem Consolidation, in a randomized comparison with single cycle Consolidation, provides an event-free survival (EFS) and overall survival (OS).
Learn More

PHO-COG-CROOP-ADVL1312; A Phase 1/2 Study of AZD1775 (MK-1775) in Combination With Oral Irinotecan in Children Adolescents and Young Adults With Relapsed or Refractory Solid Tumors

J
James Croop, MD, PhD
1-21 years
All genders
This phase I/II trial studies the side effects and best dose of WEE1 inhibitor MK-1775 and irinotecan hydrochloride in treating younger patients with solid tumors that have come back or that have not responded to standard therapy. WEE1 inhibitor MK-1775 and irinotecan hydrochloride may stop the growth of tumor cells …
Learn More